Recently, Ding et al. found that COL7A1 expression was upregulated in pancreatic cancer (PC) and served as an independent biomarker and an influential modulator of immune infiltration (Ding et al., 2023). The gene discussed is COL7A1; the disease is pancreatic neoplasm.